Comerica Bank Ionis Pharmaceuticals Inc Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Comerica Bank holds 7,615 shares of IONS stock, worth $258,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,615

Previous 21,424 64.46%

Holding current value

$258,986

Previous $1.02 Million 70.13%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $553,188 - $716,134	-13,809 Reduced 64.46%	7,615 $305,000
Q2 2024 Aug 15, 2024	SELL	$36.45 - $47.7 $658,542 - $861,795	-18,067 Reduced 45.75%	21,424 $1.02 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $5,169 - $6,586	-123 Reduced 0.31%	39,491 $1.71 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $14,492 - $17,244	-334 Reduced 0.84%	39,614 $2 Million
Q3 2023 Nov 21, 2023	BUY	$38.5 - $47.13 $1.52 Million - $1.86 Million	39,410 Added 7325.28%	39,948 $1.81 Million
Q2 2023 Aug 22, 2023	SELL	$34.73 - $43.33 $381,474 - $475,936	-10,984 Reduced 95.33%	538 $6,000
Q4 2022 Jan 26, 2023	SELL	$37.12 - $46.52 $631 - $790	-17 Reduced 0.15%	11,522 $0
Q3 2022 Oct 28, 2022	SELL	$36.54 - $48.66 $5,298 - $7,055	-145 Reduced 1.24%	11,539 $516,000
Q2 2022 Aug 02, 2022	SELL	$31.71 - $43.0 $2,251 - $3,053	-71 Reduced 0.6%	11,684 $459,000
Q4 2021 Feb 18, 2022	SELL	$25.61 - $35.1 $1,920 - $2,632	-75 Reduced 0.63%	11,755 $357,000
Q3 2021 Nov 22, 2021	SELL	$33.54 - $40.55 $126,143 - $152,508	-3,761 Reduced 24.12%	11,830 $396,000
Q2 2021 Aug 26, 2021	SELL	$34.54 - $47.25 $3,626 - $4,961	-105 Reduced 0.67%	15,591 $621,000
Q1 2021 Apr 28, 2021	SELL	$42.51 - $63.78 $14,963 - $22,450	-352 Reduced 2.19%	15,696 $705,000
Q4 2020 Jan 28, 2021	SELL	$45.3 - $60.27 $21,109 - $28,085	-466 Reduced 2.82%	16,048 $907,000
Q3 2020 Oct 30, 2020	SELL	$47.45 - $62.95 $2,941 - $3,902	-62 Reduced 0.37%	16,514 $783,000
Q2 2020 Jul 31, 2020	BUY	$46.85 - $61.05 $13,914 - $18,131	297 Added 1.82%	16,576 $977,000
Q1 2020 May 01, 2020	BUY	$41.6 - $63.4 $16,640 - $25,360	400 Added 2.52%	16,279 $769,000
Q4 2019 Feb 07, 2020	BUY	$53.85 - $65.27 $11,039 - $13,380	205 Added 1.31%	15,879 $959,000
Q3 2019 Oct 31, 2019	BUY	$59.06 - $72.15 $4,961 - $6,060	84 Added 0.54%	15,674 $939,000
Q2 2019 Aug 02, 2019	BUY	$62.09 - $86.14 $10,555 - $14,643	170 Added 1.1%	15,590 $0
Q1 2019 May 02, 2019	SELL	$52.92 - $81.17 $211 - $324	-4 Reduced 0.03%	15,420 $0
Q4 2018 Feb 06, 2019	SELL	$43.37 - $59.54 $15,960 - $21,910	-368 Reduced 2.33%	15,424 $842,000
Q3 2018 Nov 01, 2018	SELL	$42.88 - $53.7 $7,032 - $8,806	-164 Reduced 1.03%	15,792 $771,000
Q2 2018 Aug 01, 2018	BUY	$40.53 - $50.7 $324 - $405	8 Added 0.05%	15,956 $704,000
Q1 2018 May 01, 2018	SELL	$44.08 - $55.05 $5,333 - $6,661	-121 Reduced 0.75%	15,948 $731,000
Q4 2017 Feb 02, 2018	SELL	$50.3 - $64.39 $5,633 - $7,211	-112 Reduced 0.69%	16,069 $857,000
Q3 2017 Nov 06, 2017	BUY	$45.56 - $59.57 $737,206 - $963,902	16,181	16,181 $944,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account